Raras
Buscar doenças, sintomas, genes...
Epidermólise bolhosa hereditária
ORPHA:79361PCDT · SUSDOENÇA RARA
Visão / ocularInício todas idadesHerança AD/AR
Também conhecida comoEBEBH

A epidermólise bolhosa herdada (EB) abrange uma série de distúrbios caracterizados pela formação recorrente de bolhas como resultado da fragilidade estrutural da pele e de outros tecidos selecionados.

Esta página agrega dados públicos (Orphanet, MONDO, OMIM, ANVISA). Não há claims SUS específicos para esta condição.
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋
Informacoes curadas por IA — podem conter imprecisoes

A epidermólise bolhosa herdada (EB) abrange uma série de distúrbios caracterizados pela formação recorrente de bolhas como resultado da fragilidade estrutural da pele e de outros tecidos selecionados.

Pesquisas ativas
1 ensaio
5 total registrados no ClinicalTrials.gov
Publicações científicas
188 artigos
Último publicado: 2026 Feb
Medicamentos
9 registrados
IPRATROPIUM BROMIDE, CARBIDOPA, CARBIDOPA ANHYDROUS

Tem tratamento?

9 medicamentos registrados
Ver detalhes, fases e interações →
IPRATROPIUM BROMIDECARBIDOPACARBIDOPA ANHYDROUSIPRATROPIUMALBUTEROLABOBOTULINUMTOXINADEXMEDETOMIDINESOMATROPINTHEOPHYLLINE ANHYDROUS

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.8
Europe
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
PCDT disponível
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
73 sintomas
🦴
Ossos e articulações
43 sintomas
🫘
Rins
30 sintomas
🫃
Digestivo
23 sintomas
👁️
Olhos
22 sintomas
🫁
Pulmão
14 sintomas

+ 166 sintomas em outras categorias

Características mais comuns

Cílios esparsos
Ectopia lentis
Miopia
Filtro curto
Prognatismo mandibular
Anormalidade da face
443sintomas
Sem dados (443)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 443 características clínicas mais associadas, ordenadas por frequência.

Cílios esparsosSparse eyelashes
Ectopia lentis
MiopiaMyopia
Filtro curtoShort philtrum
Prognatismo mandibularMandibular prognathia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico188PubMed
Últimos 10 anos85publicações
Pico202513 papers
Linha do tempo
2026Hoje · 2026🧪 1986Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

20 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

Curadoria gene-doença

fontes oficiais
JUP
COL7A1Collagen alpha-1(VII) chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (4)
COPII-mediated vesicle transportCargo concentration in the ERCollagen biosynthesis and modifying enzymesCollagen chain trimerization
OUTRAS DOENÇAS (11)
generalized dominant dystrophic epidermolysis bullosarecessive dystrophic epidermolysis bullosatransient bullous dermolysis of the newbornnonsyndromic congenital nail disorder 8
HGNC:2214UniProt:Q02388
MMP1Interstitial collagenaseCandidate gene tested inTolerante
FUNÇÃO

Cleaves collagens of types I, II, and III at one site in the helical domain. Also cleaves collagens of types VII and X (PubMed:1645757, PubMed:2153297, PubMed:2557822). In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity (PubMed:16807369)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Activation of Matrix Metalloproteinases
EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
51.9 TPM
Estômago
10.2 TPM
Baço
3.0 TPM
Intestino delgado
2.4 TPM
Pulmão
2.3 TPM
OUTRAS DOENÇAS (1)
recessive dystrophic epidermolysis bullosa
HGNC:7155UniProt:P03956
JUPJunction plakoglobinCandidate gene tested inRestrito
FUNÇÃO

Common junctional plaque protein. The membrane-associated plaques are architectural elements in an important strategic position to influence the arrangement and function of both the cytoskeleton and the cells within the tissue. The presence of plakoglobin in both the desmosomes and in the intermediate junctions suggests that it plays a central role in the structure and function of submembranous plaques. Acts as a substrate for VE-PTP and is required by it to stimulate VE-cadherin function in end

LOCALIZAÇÃO

Cell junction, adherens junctionCell junction, desmosomeCytoplasm, cytoskeletonCell membraneCytoplasmCell junctionNucleusCell projection, axon

VIAS BIOLÓGICAS (7)
VEGFR2 mediated vascular permeabilityAdherens junctions interactionsRegulation of CDH11 functionCDH11 homotypic and heterotypic interactionsRegulation of CDH19 Expression and Function
MECANISMO DE DOENÇA

Naxos disease

An autosomal recessive disorder characterized by the association of diffuse non-epidermolytic palmoplantar keratoderma with woolly hair and cardiac abnormalities such as dilated cardiomyopathy and arrhythmogenic right ventricular dysplasia.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
1198.5 TPM
Skin Not Sun Exposed Suprapubic
1088.8 TPM
Esôfago - Mucosa
1053.2 TPM
Vagina
638.8 TPM
Glândula salivar
150.3 TPM
OUTRAS DOENÇAS (6)
Naxos diseasearrhythmogenic right ventricular dysplasia 12familial isolated arrhythmogenic ventricular dysplasia, right dominant formfamilial isolated arrhythmogenic ventricular dysplasia, left dominant form
HGNC:6207UniProt:P14923
COL17A1Collagen alpha-1(XVII) chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May play a role in the integrity of hemidesmosome and the attachment of basal keratinocytes to the underlying basement membrane The 120 kDa linear IgA disease antigen is an anchoring filament component involved in dermal-epidermal cohesion. Is the target of linear IgA bullous dermatosis autoantibodies

LOCALIZAÇÃO

Cell junction, hemidesmosomeMembraneSecreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (1)
Collagen degradation
MECANISMO DE DOENÇA

Epidermolysis bullosa, junctional 4, intermediate

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB4 is an autosomal recessive, intermediate form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. In intermediate forms of junctional epidermolysis bullosa, blistering does not lead to the formation of chronic granulation tissue and does not affect the lifespan of affected individuals. Nail dystrophy and dental enamel defects are present. Scarring or non-scarring alopecia and diffuse hair loss may occur. JEB4 patients manifest blisters at birth or shortly afterward. Blisters may heal with atrophic scarring and variable hypo- or hyperpigmentation. Oral mucosa may be involved.

OUTRAS DOENÇAS (5)
epidermolysis bullosa, junctional 4, intermediateepithelial recurrent erosion dystrophylate-onset junctional epidermolysis bullosageneralized junctional epidermolysis bullosa non-Herlitz type
HGNC:2194UniProt:Q9UMD9
DSPDesmoplakinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:25733715). Critical for cell-cell adhesion in early stage blastocysts and progression through proamniotic cavity formation (By similarity). Not required for preimplantation morphogenic process in blastocysts (By similarity). Required for keratin filament anchoring at the desmosome junction and subsequent organization of the keratin intermediate filament network within the cytoplas

LOCALIZAÇÃO

Cell projection, axonCell junction, desmosomeCell membraneCytoplasmNucleus

VIAS BIOLÓGICAS (6)
Apoptotic cleavage of cell adhesion proteinsNeutrophil degranulationKeratinizationFormation of the cornified envelopeRND1 GTPase cycle
MECANISMO DE DOENÇA

Keratoderma, palmoplantar, striate 2

A dermatological disorder characterized by thickening of the skin on the palms (linear pattern) and the soles (island-like pattern) and flexor aspect of the fingers. Abnormalities of the nails, the teeth and the hair are rarely present.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
1294.4 TPM
Skin Not Sun Exposed Suprapubic
1155.3 TPM
Esôfago - Mucosa
647.4 TPM
Vagina
416.9 TPM
Glândula salivar
87.7 TPM
OUTRAS DOENÇAS (13)
arrhythmogenic cardiomyopathy with wooly hair and keratodermakeratosis palmoplantaris striata 2lethal acantholytic epidermolysis bullosacardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis
HGNC:3052UniProt:P15924
EXPH5Exophilin-5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May act as Rab effector protein and play a role in vesicle trafficking

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS4 is an autosomal recessive disorder characterized by mild skin fragility with onset at birth or in early childhood, associated with acral blistering with hemorrhagic crusts. Skin fragility improves with age in most patients, although mottled pigmentation may later develop on the trunk and proximal limbs.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
35.1 TPM
Skin Not Sun Exposed Suprapubic
31.2 TPM
Cerebelo
26.1 TPM
Cérebro - Hemisfério cerebelar
24.0 TPM
Esôfago - Mucosa
10.3 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive
HGNC:30578UniProt:Q8NEV8
ITGB4Integrin beta-4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Integrin alpha-6/beta-4 is a receptor for laminin. Plays a critical structural role in the hemidesmosome of epithelial cells. Is required for the regulation of keratinocyte polarity and motility. ITGA6:ITGB4 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGA6:ITGB4 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:22351760). ITGA6:ITGB4 binds to IGF2 and this binding is essential for IGF2 signaling (PubMed:28873464)

LOCALIZAÇÃO

Cell membraneCell junction, hemidesmosome

VIAS BIOLÓGICAS (5)
Type I hemidesmosome assemblyLaminin interactionsAssembly of collagen fibrils and other multimeric structuresSyndecan interactionsDifferentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
MECANISMO DE DOENÇA

Epidermolysis bullosa, junctional 5A, intermediate

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB5A is an autosomal recessive, intermediate form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. In intermediate forms of junctional epidermolysis bullosa, blistering does not lead to the formation of chronic granulation tissue and does not affect the lifespan of affected individuals. Nail dystrophy and dental enamel defects are present. Scarring or non-scarring alopecia and diffuse hair loss may occur.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
362.3 TPM
Skin Sun Exposed Lower leg
180.2 TPM
Glândula salivar
169.1 TPM
Skin Not Sun Exposed Suprapubic
158.6 TPM
Vagina
91.3 TPM
OUTRAS DOENÇAS (6)
junctional epidermolysis bullosa with pyloric atresiaepidermolysis bullosa, junctional 5A, intermediateepidermolysis bullosa simplex 5C, with pyloric atresiaaplasia cutis congenita
HGNC:6158UniProt:P16144
CD151CD151 antigenDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (TERMs), which act as platforms for receptor clustering and signaling. Plays a role in various cellular and molecular mechanism through its association with both integrin and non-integrin proteins. These interactions facilitate critical cellular functions, including cell-to-cell communication, wound healing, platelet aggregation, trafficking, cell motility, and angiogenesis (PubMed:17045834, PubM

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Type I hemidesmosome assembly
MECANISMO DE DOENÇA

Epidermolysis bullosa simplex 7, with nephropathy and deafness

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS7 is an autosomal recessive disorder characterized by the association of skin blistering, hereditary nephritis, sensorineural deafness, and beta-thalassemia minor. Skin blistering is present at birth, particularly in the tibial area but also scattered on other parts of the body.

OUTRAS DOENÇAS (1)
epidermolysis bullosa simplex 7, with nephropathy and deafness
HGNC:1630UniProt:P48509
KLHL24Kelch-like protein 24Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Necessary to maintain the balance between intermediate filament stability and degradation, a process that is essential for skin integrity (PubMed:27889062). As part of the BCR(KLHL24) E3 ubiquitin ligase complex, mediates ubiquitination of KRT14 and controls its levels during keratinocytes differentiation (PubMed:27798626). Specifically reduces kainate receptor-mediated currents in hippocampal neurons, most probably by modulating channel properties (By similarity). Has a crucial role in cardiac

LOCALIZAÇÃO

PerikaryonCell projection, axonCytoplasmCell junction, desmosomeCell junction, adherens junction

MECANISMO DE DOENÇA

Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS6 is an autosomal dominant disorder presenting at birth with extensive skin defects on the extremities, leaving behind hypopigmentation and atrophy with a whirled pattern. Cutaneous fragility and generalized blistering persist during childhood and decrease in adulthood. Adult patients have dyspigmentation and atrophy of the skin, scars, follicular atrophoderma, sparse body hair, progressive diffuse alopecia of the scalp, diffuse palmoplantar keratoderma, and nail changes.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
27.7 TPM
Pulmão
26.2 TPM
Tireoide
25.8 TPM
Cervix Ectocervix
24.9 TPM
Músculo esquelético
24.1 TPM
OUTRAS DOENÇAS (2)
epidermolysis bullosa simplex 6, generalized, with scarring and hair losscardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies
HGNC:25947UniProt:Q6TFL4
DSTDystoninDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Cytoskeletal linker protein. Acts as an integrator of intermediate filaments, actin and microtubule cytoskeleton networks. Required for anchoring either intermediate filaments to the actin cytoskeleton in neural and muscle cells or keratin-containing intermediate filaments to hemidesmosomes in epithelial cells. The proteins may self-aggregate to form filaments or a two-dimensional mesh. Regulates the organization and stability of the microtubule network of sensory neurons to allow axonal transpo

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cytoskeleton, stress fiberCell projection, axonCytoplasm, myofibril, sarcomere, Z lineCytoplasm, myofibril, sarcomere, H zoneCell junction, hemidesmosomeNucleusNucleus envelopeMembraneEndoplasmic reticulum membraneCytoplasm, cell cortexCell membrane

VIAS BIOLÓGICAS (6)
Type I hemidesmosome assemblyRND1 GTPase cycleRHOU GTPase cycleRHOV GTPase cycleRND3 GTPase cycle
MECANISMO DE DOENÇA

Neuropathy, hereditary sensory and autonomic, 6

A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN6 is a severe autosomal recessive disorder characterized by neonatal hypotonia, respiratory and feeding difficulties, lack of psychomotor development, and autonomic abnormalities including labile cardiovascular function, lack of corneal reflexes leading to corneal scarring, areflexia, and absent axonal flare response after intradermal histamine injection.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
76.7 TPM
Skin Not Sun Exposed Suprapubic
61.6 TPM
Skin Sun Exposed Lower leg
59.8 TPM
Cólon sigmoide
59.1 TPM
Útero
58.5 TPM
OUTRAS DOENÇAS (2)
epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiencyhereditary sensory and autonomic neuropathy type 6
HGNC:1090UniProt:Q03001
FERMT1Fermitin family homolog 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in cell adhesion. Contributes to integrin activation. When coexpressed with talin, potentiates activation of ITGA2B. Required for normal keratinocyte proliferation. Required for normal polarization of basal keratinocytes in skin, and for normal cell shape. Required for normal adhesion of keratinocytes to fibronectin and laminin, and for normal keratinocyte migration to wound sites. May mediate TGF-beta 1 signaling in tumor progression

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell junction, focal adhesionCell projection, ruffle membrane

MECANISMO DE DOENÇA

Kindler syndrome

An autosomal recessive skin disorder characterized by skin blistering, photosensitivity, progressive poikiloderma, and extensive skin atrophy. Additional clinical features include gingival erosions, ocular, esophageal, gastrointestinal and urogenital involvement, and an increased risk of mucocutaneous malignancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
23.1 TPM
Esôfago - Mucosa
21.2 TPM
Skin Not Sun Exposed Suprapubic
21.1 TPM
Skin Sun Exposed Lower leg
19.7 TPM
Vagina
12.1 TPM
OUTRAS DOENÇAS (1)
Kindler syndrome
HGNC:15889UniProt:Q9BQL6
ITGA6Integrin alpha-6Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Integrin alpha-6/beta-1 (ITGA6:ITGB1) is a receptor for laminin on platelets (By similarity). Integrin alpha-6/beta-1 (ITGA6:ITGB1) is present in oocytes and is involved in sperm-egg fusion (By similarity). Integrin alpha-6/beta-4 (ITGA6:ITGB4) is a receptor for laminin in epithelial cells and it plays a critical structural role in the hemidesmosome (By similarity). ITGA6:ITGB4 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGA6:ITGB4 bin

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (10)
Basigin interactionsIntegrin cell surface interactionsLaminin interactionsType I hemidesmosome assemblyAssembly of collagen fibrils and other multimeric structures
MECANISMO DE DOENÇA

Epidermolysis bullosa, junctional 6, with pyloric atresia

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB6 is an autosomal recessive form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. Clinical manifestations include severe blistering, atrophic scarring, nail dystrophy, and pyloric atresia. Congenital absence of skin (aplasia cutis congenita) is common, and ear anomalies are also relatively common. Disease course is usually severe and often lethal in the neonatal period.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
283.3 TPM
Glândula salivar
82.2 TPM
Mama
71.6 TPM
Útero
65.3 TPM
Tecido adiposo
63.7 TPM
OUTRAS DOENÇAS (2)
epidermolysis bullosa, junctional 6, with pyloric atresiajunctional epidermolysis bullosa with pyloric atresia
HGNC:6142UniProt:P23229
LAMC2Laminin subunit gamma-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Ladsin exerts cell-scattering activity toward a wide variety of cells, including epithelial, endothelial, and fibroblastic cells

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (10)
Type I hemidesmosome assemblyMET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAttachment of bacteria to epithelial cellsLaminin interactions
MECANISMO DE DOENÇA

Epidermolysis bullosa, junctional 3A, intermediate

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB3A is an autosomal recessive, intermediate form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. In intermediate forms of junctional epidermolysis bullosa, blistering does not lead to the formation of chronic granulation tissue and does not affect the lifespan of affected individuals. Nail dystrophy and dental enamel defects are present. Scarring or non-scarring alopecia and diffuse hair loss may occur.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
23.5 TPM
Pulmão
22.2 TPM
Skin Sun Exposed Lower leg
21.3 TPM
Tireoide
16.5 TPM
Mama
14.0 TPM
OUTRAS DOENÇAS (4)
epidermolysis bullosa, junctional 3A, intermediateepidermolysis bullosa, junctional 3B, severejunctional epidermolysis bullosa Herlitz typegeneralized junctional epidermolysis bullosa non-Herlitz type
HGNC:6493UniProt:Q13753
LAMA3Laminin subunit alpha-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components Laminin-5 is thought to be involved in (1) cell adhesion via integrin alpha-3/beta-1 in focal adhesion and integrin alpha-6/beta-4 in hemidesmosomes, (2) signal transduction via tyrosine phosphorylation of pp125-FAK and p80, (3) differentiation of keratinocytes

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (10)
Type I hemidesmosome assemblyMET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAttachment of bacteria to epithelial cellsLaminin interactions
MECANISMO DE DOENÇA

Epidermolysis bullosa, junctional 2A, intermediate

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB2A is an autosomal recessive, intermediate form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. In intermediate forms of junctional epidermolysis bullosa, blistering does not lead to the formation of chronic granulation tissue and does not affect the lifespan of affected individuals. Nail dystrophy and dental enamel defects are present. Scarring or non-scarring alopecia and diffuse hair loss may occur.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
30.0 TPM
Útero
28.4 TPM
Skin Sun Exposed Lower leg
26.2 TPM
Nervo tibial
25.9 TPM
Vagina
25.3 TPM
OUTRAS DOENÇAS (5)
laryngo-onycho-cutaneous syndromeepidermolysis bullosa, junctional 2A, intermediateepidermolysis bullosa, junctional 2B, severejunctional epidermolysis bullosa Herlitz type
HGNC:6483UniProt:Q16787
KRT14Keratin, type I cytoskeletal 14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

The nonhelical tail domain is involved in promoting KRT5-KRT14 filaments to self-organize into large bundles and enhances the mechanical properties involved in resilience of keratin intermediate filaments in vitro

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (5)
Type I hemidesmosome assemblyKeratinizationFormation of the cornified envelopeDevelopmental Lineage of Mammary Gland Myoepithelial CellsDifferentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
MECANISMO DE DOENÇA

Epidermolysis bullosa simplex 1A, generalized severe

A form of epidermolysis bullosa simplex, a group of skin fragility disorders characterized by skin blistering due to cleavage within the basal layer of keratinocytes, and erosions caused by minor mechanical trauma. There is a broad spectrum of clinical severity ranging from minor blistering on the feet, to subtypes with extracutaneous involvement and a lethal outcome. EBS1A is an autosomal dominant form characterized by generalized intraepidermal skin blistering that begins and is very prominent at birth. EBS1A may be life-threatening in the first year of life. Tendency to blistering diminishes in adolescence.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
8476.9 TPM
Skin Sun Exposed Lower leg
7304.4 TPM
Vagina
763.1 TPM
Esôfago - Mucosa
645.2 TPM
Glândula salivar
535.5 TPM
OUTRAS DOENÇAS (7)
Naegeli-Franceschetti-Jadassohn syndromeepidermolysis bullosa simplex 1B, generalized intermediateepidermolysis bullosa simplex 1C, localizedepidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive
HGNC:6416UniProt:P02533
PKP1Plakophilin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:23444369). Plays a role in desmosome protein expression regulation and localization to the desmosomal plaque, thereby maintaining cell sheet integrity and anchorage of desmosomes to intermediate filaments (PubMed:10852826, PubMed:23444369). Required for localization of DSG3 and YAP1 to the cell membrane in keratinocytes in response to mechanical strain, via the formation of an int

LOCALIZAÇÃO

Cell junction, desmosomeNucleusCytoplasm, perinuclear regionCytoplasmCell membraneCytoplasm, Stress granule

VIAS BIOLÓGICAS (4)
Apoptotic cleavage of cell adhesion proteinsNeutrophil degranulationKeratinizationFormation of the cornified envelope
MECANISMO DE DOENÇA

Ectodermal dysplasia-skin fragility syndrome

A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Characterized by features of both cutaneous fragility and congenital ectodermal dysplasia affecting skin, hair and nails. There is no evidence of significant abnormalities in other epithelia or tissues. Desmosomes in the skin are small and poorly formed with widening of keratinocyte intercellular spaces and perturbed desmosome/keratin intermediate filament interactions.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
1128.8 TPM
Skin Not Sun Exposed Suprapubic
985.1 TPM
Esôfago - Mucosa
567.5 TPM
Vagina
298.1 TPM
Próstata
41.4 TPM
OUTRAS DOENÇAS (1)
epidermolysis bullosa simplex due to plakophilin deficiency
HGNC:9023UniProt:Q13835
LAMB3Laminin subunit beta-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (10)
Type I hemidesmosome assemblyMET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAttachment of bacteria to epithelial cellsLaminin interactions
MECANISMO DE DOENÇA

Epidermolysis bullosa, junctional 1B, severe

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. Junctional epidermolysis bullosa is characterized by blistering that occurs at the level of the lamina lucida in the skin basement membrane. JEB1B is an autosomal recessive, severe form characterized by bullous lesions appearing at birth, and extensive denudation of skin and mucous membranes that may be hemorrhagic. Death occurs usually within the first six months of life. Occasionally, children survive to teens.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
57.8 TPM
Skin Not Sun Exposed Suprapubic
54.8 TPM
Esôfago - Mucosa
54.6 TPM
Glândula salivar
50.2 TPM
Vagina
46.7 TPM
OUTRAS DOENÇAS (5)
junctional epidermolysis bullosa, non-Herlitz typejunctional epidermolysis bullosa Herlitz typeamelogenesis imperfecta type 1Aamelogenesis imperfecta type 1
HGNC:6490UniProt:Q13751
PLECPlectinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Interlinks intermediate filaments with microtubules and microfilaments and anchors intermediate filaments to desmosomes or hemidesmosomes. Could also bind muscle proteins such as actin to membrane complexes in muscle. May be involved not only in the filaments network, but also in the regulation of their dynamics. Structural component of muscle. Isoform 9 plays a major role in the maintenance of myofiber integrity

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell junction, hemidesmosomeCell projection, podosome

VIAS BIOLÓGICAS (3)
Caspase-mediated cleavage of cytoskeletal proteinsType I hemidesmosome assemblyAssembly of collagen fibrils and other multimeric structures
MECANISMO DE DOENÇA

Epidermolysis bullosa simplex 5C, with pyloric atresia

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS5C is an autosomal recessive disorder characterized by severe skin blistering at birth and congenital pyloric atresia. Death usually occurs in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
241.5 TPM
Fibroblastos
212.0 TPM
Músculo esquelético
151.2 TPM
Aorta
144.6 TPM
Artéria tibial
138.0 TPM
OUTRAS DOENÇAS (6)
autosomal recessive limb-girdle muscular dystrophy type 2Qepidermolysis bullosa simplex 5A, Ogna typeepidermolysis bullosa simplex 5C, with pyloric atresiaepidermolysis bullosa simplex 5B, with muscular dystrophy
HGNC:9069UniProt:Q15149
KRT5Keratin, type II cytoskeletal 5Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Required for the formation of keratin intermediate filaments in the basal epidermis and maintenance of the skin barrier in response to mechanical stress (By similarity). Regulates the recruitment of Langerhans cells to the epidermis, potentially by modulation of the abundance of macrophage chemotactic cytokines, macrophage inflammatory cytokines and CTNND1 localization in keratinocytes (By similarity)

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (7)
Type I hemidesmosome assemblyKeratinizationFormation of the cornified envelopeDevelopmental Lineage of Mammary Stem CellsDevelopmental Lineage of Mammary Gland Luminal Epithelial Cells
MECANISMO DE DOENÇA

Epidermolysis bullosa simplex 2A, generalized severe

A form of epidermolysis bullosa simplex, a group of skin fragility disorders characterized by skin blistering due to cleavage within the basal layer of keratinocytes, and erosions caused by minor mechanical trauma. There is a broad spectrum of clinical severity ranging from minor blistering on the feet, to subtypes with extracutaneous involvement and a lethal outcome. EBS2A is an autosomal dominant, severe form characterized by extensive intraepidermal blistering from the time of birth with herpetiform marginal spreading and central healing. Oral mucosal involvement, nail dystrophy, onychogryposis, formation of milia, and palmoplantar hyperkeratosis are common features.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
7391.8 TPM
Skin Not Sun Exposed Suprapubic
5833.1 TPM
Skin Sun Exposed Lower leg
5020.4 TPM
Vagina
3291.8 TPM
Glândula salivar
340.6 TPM
OUTRAS DOENÇAS (11)
epidermolysis bullosa simplex 2F, with mottled pigmentationepidermolysis bullosa simplex 2B, generalized intermediateepidermolysis bullosa simplex 2E, with migratory circinate erythemaDowling-Degos disease 1
HGNC:6442UniProt:P13647
ITGA3Integrin alpha-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Integrin alpha-3/beta-1 is a receptor for fibronectin, laminin, collagen, epiligrin, thrombospondin and CSPG4. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration (Microbial infection) Integrin ITGA3:I

LOCALIZAÇÃO

Cell membraneCell projection, invadopodium membraneCell projection, filopodium membrane

VIAS BIOLÓGICAS (4)
Basigin interactionsIntegrin cell surface interactionsMET activates PTK2 signalingLaminin interactions
MECANISMO DE DOENÇA

Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB7 is an autosomal recessive form associated with congenital nephrotic syndrome and interstitial lung disease. The respiratory and renal features predominate, and lung involvement accounts for the lethal course of the disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
186.8 TPM
Aorta
178.4 TPM
Artéria coronária
158.9 TPM
Pulmão
150.0 TPM
Tireoide
139.5 TPM
OUTRAS DOENÇAS (1)
epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
HGNC:6139UniProt:P26006

Medicamentos e terapias

IPRATROPIUM BROMIDEPhase 3

Mecanismo: Muscarinic acetylcholine receptor M3 antagonist

CARBIDOPAPhase 3

Mecanismo: DOPA decarboxylase inhibitor

CARBIDOPA ANHYDROUSPhase 3

Mecanismo: DOPA decarboxylase inhibitor

IPRATROPIUMPhase 3

Mecanismo: Muscarinic acetylcholine receptor M3 antagonist

ALBUTEROLPhase 3

Mecanismo: Beta-2 adrenergic receptor agonist

ABOBOTULINUMTOXINAPhase 2

Mecanismo: Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor

DEXMEDETOMIDINEPhase 2

Mecanismo: Adrenergic receptor alpha-2 agonist

SOMATROPINPhase 2

Mecanismo: Growth hormone receptor agonist

THEOPHYLLINE ANHYDROUSPhase 2

Mecanismo: Phosphodiesterase 4 inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

1.428 variantes patogênicas registradas no ClinVar.

🧬 COL7A1: NM_000094.4(COL7A1):c.7864C>G (p.Arg2622Gly) ()
🧬 COL7A1: NM_000094.4(COL7A1):c.107C>G (p.Ala36Gly) ()
🧬 COL7A1: NM_000094.4(COL7A1):c.4040G>C (p.Gly1347Ala) ()
🧬 COL7A1: NM_000094.4(COL7A1):c.6191G>C (p.Gly2064Ala) ()
🧬 COL7A1: NM_000094.4(COL7A1):c.4980+5G>A ()
Ver todas no ClinVar

Vias biológicas (Reactome)

54 vias biológicas associadas aos genes desta condição.

Collagen degradation Fibronectin matrix formation Collagen biosynthesis and modifying enzymes Assembly of collagen fibrils and other multimeric structures COPII-mediated vesicle transport Integrin cell surface interactions Anchoring fibril formation Laminin interactions Cargo concentration in the ER Collagen chain trimerization Degradation of the extracellular matrix Activation of Matrix Metalloproteinases Basigin interactions Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Interleukin-4 and Interleukin-13 signaling Adherens junctions interactions VEGFR2 mediated vascular permeability Neutrophil degranulation Keratinization Formation of the cornified envelope RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle CDC42 GTPase cycle RHOQ GTPase cycle RHOH GTPase cycle RHOJ GTPase cycle Regulation of CDH11 function Regulation of CDH19 Expression and Function Regulation of CDH1 Function Degradation of CDH1 Regulation of CDH1 posttranslational processing and trafficking to plasma membrane CDH11 homotypic and heterotypic interactions Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Type I hemidesmosome assembly Apoptotic cleavage of cell adhesion proteins RND3 GTPase cycle RND1 GTPase cycle Syndecan interactions Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin RHOU GTPase cycle RHOV GTPase cycle RND2 GTPase cycle Developmental Lineage of Mammary Gland Luminal Epithelial Cells Developmental Lineage of Mammary Gland Alveolar Cells Developmental Lineage of Mammary Gland Myoepithelial Cells Developmental Lineage of Mammary Stem Cells Non-integrin membrane-ECM interactions MET activates PTK2 signaling Attachment of bacteria to epithelial cells Formation of the dystrophin-glycoprotein complex (DGC) Developmental Lineage of Pancreatic Ductal Cells ECM proteoglycans Caspase-mediated cleavage of cytoskeletal proteins

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 36
2Fase 26
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 9 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Epidermólise bolhosa hereditária

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

5 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
83 papers (10 anos)
#1

The lived experience and supportive care needs of Australian parents caring for children with Epidermolysis Bullosa: a qualitative descriptive analysis.

Orphanet journal of rare diseases2025 Nov 29

Inherited epidermolysis bullosa (EB) is a rare, incurable genodermatosis characterised with recurrent skin blistering and mucosal fragility. Wound care and nursing are critical to everyday lives of children living with EB, while the profound effect of caring for a child with a painful genetic condition leaves a significant effect on quality of life of parents and the family. This study aimed to better understand the lived experiences and supportive care needs of parents of children with EB in Australia. Interpretative phenomenological analysis was used, and semi structured focus groups interviews were conducted with Australian parents of children with EB. This included 18 parents of children with EB simplex (EBS), 9 parents of children with Junctional EB (JEB) and 16 parents of children with Dystrophic EB (DEB). The data were thematically analysed, all participants are residents of Australia and therefore reflect the services in this geographical location. Six overarching themes included: practical needs, emotional needs, informational needs, psychological needs, social needs and physical needs. Parents caring for a child with EB in Australia face numerous needs and challenges regardless of EB severity which highlights the need for provision of better more comprehensive services to deliver family focused holistic EB care that can alleviate some of the burden of EB and improve the quality of life for families and individuals living with EB.

#2

Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol.

PloS one2025

Inherited Epidermolysis Bullosa (EB) is a group of rare, genetic skin diseases characterized by extreme fragility of the skin and mucous membranes, leading to blistering and wounds in response to minimal trauma or friction. These clinical manifestations significantly reduce health-related quality of life (HRQoL). The objective of this protocol article is to provide information about the methods planned to be used to assess the measurement properties of HRQoL instruments specifically developed for EB patients of all age groups through a systematic review and meta-analysis. The protocol followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocols (PRISMA-P) guideline. The literature search will be conducted in PubMed, Web of Science (WOS) and EMBASE, including terminology that aligns with the four key elements of the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) research question (construct, target population, measurement properties and type of PROM), as well as the terminology proposed by COSMIN for measurement properties. Studies that include information on measurement properties (specifically, validity and/or reliability) with a sample of patients with inherited EB will be selected. Both title and abstract screening and full text review, will be conducted by two independent reviewers using the Rayyan tool. In addition, the risk of bias will be assessed using the COSMIN-Risk of Bias checklist. The data from each study and each measurement property will be summarized in accordance with the COSMIN guidelines. The evidence gathered will strive to adjudicate data on measurements properties of HRQoL instruments used in EB patients, and the limitations of the future systematic review will be discussed. Ultimately, results of the future systematic review will help develop more personalized guidelines for the assessment of HRQoL in EB patients of all age groups. The protocol is registered in OSF with registration number vrm87: https://osf.io/vrm87/.

#3

Junctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion.

International journal of molecular sciences2025 Jul 29

Inherited epidermolysis bullosa (EB) is a heterogeneous clinical entity that includes over 30 phenotypically and/or genotypically distinct inherited disorders, characterized by mechanical skin fragility and bullae formation. Junctional EB (JEB) is an autosomal recessive disease characterized by an intermediated cleavage level within the skin layers, commonly at the "lamina lucida". Laryngo-onycho-cutaneous syndrome (LOC) is an extremely rare variant of JEB, characterized by granulation tissue formation in specific body sites (skin, larynx, and nails). Although most cases of JEB are caused by pathogenic variants occurring in the genes encoding for classical components of the lamina lucida, such as laminin 332 (LAMA3, LAMB3, LAMC2), integrin α6β4 (ITGA6, ITGB4), and collagen XVII (COL17A1), other variants have also been described. We report the case of a 4-month-old male infant who presented with recurrent bullous and erosive lesions from the first month of life. At the first dermatological evaluation, the patient was agitated and exhibited hoarse breathing, a clinical sign suggestive of laryngeal involvement. Multiple polygonal skin erosions were observed on the cheeks, along with similar isolated, roundish lesions on the scalp and legs. Notably, nail dystrophy and near-complete anonychia were evident on the left first and fifth toes. Due to the coexistence of skin erosions and nail dystrophy in such a young infant, a congenital bullous disorder was suspected, prompting molecular analysis of all potentially involved genes. In the patient's DNA, clinical exome sequencing (CES) identified a pathogenic variant, apparently in homozygosity, in the exon 1 of the LAMA3 gene (18q11.2; NM_000227.6): c.47G > A;p.Trp16*. The presence of this variant was confirmed, in heterozygosity, in the genomic DNA of the patient's mother, while it was absent in the father's DNA. Subsequently, trio-based SNP array analysis was performed, revealing a paternally derived pathogenic microdeletion encompassing the LAMA3 locus (18q11.2). To our knowledge, this is the first reported case of JEB with a LOC-like phenotype caused by a maternally inherited monoallelic nonsense mutation in LAMA3, unmasked by an almost complete deletion of the paternal allele. The combined use of exome sequencing and SNP array is proving essential for elucidating autosomal recessive diseases with a discordant segregation. This is pivotal for providing accurate genetic counseling to parents regarding future pregnancies.

#4

Clinical and Allelic Heterogeneity in a Small Cohort of Patients with Inherited Epidermolysis Bullosa.

International journal of molecular sciences2025 Jun 16

Inherited epidermolysis bullosa (EB) comprises a group of genetic disorders characterized by fragile skin that blisters easily. Targeted therapies for EB necessitate personalized approaches, underscoring the importance of precise diagnostics through genetic analysis and skin biopsy using transmission electron microscopy and/or immunohistochemistry. This study highlights the application of whole-exome sequencing (WES) to identify key pathogenic variants associated with EB. Most identified variants were associated with the recessive form of dystrophic EB, including four novel COL7A1 mutations: p.Leu1488ArgfsTer222, c.7759-3C>G, p.Gln1886Ter, and c.6501+6T>C, as well as recurrent variants p.Lys142Arg and p.Gly2049Glu. Additionally, variants were detected in KRT5 (c.971T>C, p.Val324Ala), associated with EB simplex, and in LAMB3 (c.2500C>T, p.Gln834Ter) in the homozygous state, associated with junctional EB. In silico splice prediction tools suggested disrupted splicing in both cases. One patient received topical gentamicin therapy targeting the nonsense mutation p.Gln1886Ter. These findings underscore the utility of WES in EB diagnostics, broaden the mutation spectrum, and contribute to the understanding of genotype-phenotype correlations in adult patients with EB.

#5

An International Online Survey on Oral Hygiene Issues in Patients with Epidermolysis Bullosa.

Dentistry journal2025 Aug 30

Background: Inherited epidermolysis bullosa (EB) includes a group of rare genetic disorders affecting the skin and mucous membranes. These disorders are characterized by extreme fragility and blister formation after minimal or no trauma. Oral and systemic manifestations vary by subtype; the more severe forms often present with extensive intra-oral blistering, scarring, microstomia, vestibular obliteration, ankyloglossia, and-in some cases-oral cancer. This study aims to collect data on oral-health practices and challenges in people with EB to inform preventive strategies and dental care. Methods: An international, structured online questionnaire with 31 items was distributed to individuals with a confirmed diagnosis of EB. The survey explored clinical and oral manifestations, home-care routines (oral hygiene and diet), experiences with dental professionals, and the impact of oral health on quality of life. Results: Eighty-two questionnaires were completed. Dystrophic EB was the most often reported subtype (69.5%). Most respondents (67.1%) experienced recurrent oral blisters and/or erosions. Many reported relying exclusively on soft foods and struggling with mechanical plaque removal because of microstomia and pseudo-syndactyly. Severe oral pain hindered effective brushing in 17% of participants. Hand contractures and microstomia interfered with oral hygiene in 74% and 31% of participants, respectively. Nearly 30% sought dental care only when in pain. Among those who did not attend regular check-ups or hygiene sessions (44.6%), the most cited reason was that dental clinics were inadequately equipped or trained to manage EB. Conclusions: Because dental procedures carry significant risks for patients with EB, preventive care should begin in early childhood. Yet many patients are still insufficiently informed about essential preventive measures and lack access to dental professionals trained in EB management.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC97 artigos no totalmostrando 85

2025

The lived experience and supportive care needs of Australian parents caring for children with Epidermolysis Bullosa: a qualitative descriptive analysis.

Orphanet journal of rare diseases
2025

An International Online Survey on Oral Hygiene Issues in Patients with Epidermolysis Bullosa.

Dentistry journal
2025

Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol.

PloS one
2025

Stem cell therapy: a promising frontier in modern medicine with a comprehensive overview of their biology and potential therapeutic applications in chronic non-healing cutaneous injuries.

Inflammopharmacology
2025

Junctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion.

International journal of molecular sciences
2025

Locally Advanced Cervical Cancer in a Patient with Epidermolysis Bullosa Treated with Concurrent Chemoradiotherapy and Electronic Brachytherapy.

Reports (MDPI)
2025

Treatment progress of inherited epidermolysis bullosa.

Expert opinion on biological therapy
2025

Clinical and Allelic Heterogeneity in a Small Cohort of Patients with Inherited Epidermolysis Bullosa.

International journal of molecular sciences
2025

Missense and Inframe Pathogenic Variants in PLEC Lead to Minimal or Delayed-Onset Muscular Dystrophy in Autosomal Recessive Epidermolysis Bullosa Simplex: A Genotype-Phenotype Correlation in Nine Cases.

The Journal of dermatology
2025

Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline.

The British journal of dermatology
2025

A pathogenic COL7A1 variant highlights semi-dominant inheritance in dystrophic epidermolysis bullosa.

BMC medical genomics
2025

Colchicine as a treatment option for inherited epidermolysis bullosa.

Clinical and experimental dermatology
2024

Correlation between measured oral health and oral health-related quality of life in people with epidermolysis bullosa: a prospective cohort study.

BMC oral health
2025

Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseases.

Journal of the European Academy of Dermatology and Venereology : JEADV
2024

Epidemiological Characteristics of Inherited Epidermolysis Bullosa in an Eastern European Population.

Journal of clinical medicine
2024

Descriptive Study of the Clinical and Molecular Features of Epidermolysis Bullosa Patients in a Romanian European Reference Network-Skin Affiliated Reference Center.

Cureus
2024

Experience of dupilumab treatment in inherited epidermolysis bullosa: A short series.

Journal of the American Academy of Dermatology
2024

"Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires.

Italian journal of pediatrics
2024

Battling a rarity: A case of kindler syndrome from a developing country.

SAGE open medical case reports
2023

Diagnosis, Management, and Outcome of Bart's Syndrome Observed in a Sub-Saharan African Country (Senegal, Dakar): 2 Case Reports.

Case reports in dermatology
2023

A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab.

The Journal of dermatological treatment
2023

Consensus-based guidelines for the provision of palliative and end-of-life care for people living with epidermolysis bullosa.

Orphanet journal of rare diseases
2023

Phenotype and genotype correlation of inherited epidermolysis bullosa in Indonesia.

The Australasian journal of dermatology
2023

Integrin alpha 6 homozygous splice-site mutation causes a new form of junctional epidermolysis bullosa in Charolais cattle.

Genetics, selection, evolution : GSE
2023

Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.

Indian journal of pathology &amp; microbiology
2022

[Genome Editing in Therapy of Genodermatoses].

Molekuliarnaia biologiia
2022

Diverse clinical and genetic characteristics of six cases of inherited epidermolysis bullosa.

Experimental and therapeutic medicine
2023

Oral health status in patients with inherited epidermolysis bullosa: a comparative multicenter study.

Quintessence international (Berlin, Germany : 1985)
2023

Epidemiology of inherited epidermolysis bullosa in Germany.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

Eye Involvement and Management in Inherited Epidermolysis Bullosa.

Drugs
2023

Burden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa in France.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

Potential di-genic contribution to guttate leukoderma as the predominant feature of epidermolysis bullosa simplex.

Experimental dermatology
2022

Folliculitis decalvans and dystrophic epidermolysis bullosa: a significant association.

The British journal of dermatology
2022

Stomatological management and implant-supported rehabilitation in a patient with recessive dystrophic epidermolysis bullosa.

Clinical case reports
2022

Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.

Cells
2022

Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center.

Italian journal of pediatrics
2021

INHERITED EPIDERMOLYSIS BULLOSA IN NEWBORN (CASE STUDY).

Wiadomosci lekarskie (Warsaw, Poland : 1960)
2022

Oral status in patients with inherited epidermolysis bullosa: A multicentric observational study.

Journal of the American Academy of Dermatology
2022

Case of inherited epidermolysis bullosa simplex with KLHL24 gene mutation in Japan.

The Journal of dermatology
2021

Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases.

Journal of the European Academy of Dermatology and Venereology : JEADV
2021

Inherited epidermolysis bullosa: epidemiology and patient care in Slovenia with a review of the updated classification.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica
2021

A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.

Antibodies (Basel, Switzerland)
2021

Prevalence and antimicrobial resistance profile of Staphylococcus aureus in inherited epidermolysis bullosa: a cross-sectional multicenter study in Brazil.

International journal of dermatology
2021

Periodontal Manifestation in a Patient with Kindler Syndrome.

Case reports in dentistry
2021

Epigenetic and metabolic regulation of epidermal homeostasis.

Experimental dermatology
2021

Immunofluorescence mapping, electron microscopy and genetics in the diagnosis and sub-classification of inherited epidermolysis bullosa: a single-centre retrospective comparative study of 87 cases with long-term follow-up.

Journal of the European Academy of Dermatology and Venereology : JEADV
2020

Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2020

A novel frameshift mutation in the FERMT1 gene in a Chinese patient with Kindler syndrome.

Experimental and therapeutic medicine
2020

Emaciation, Congestive Heart Failure, and Systemic Amyloidosis in Severe Recessive Dystrophic Epidermolysis Bullosa: Possible Internal Complications Due to Skin-Derived Inflammatory Cytokines Derived from the Injured Skin.

Dermatopathology (Basel, Switzerland)
2020

Genotypic and Phenotypic Analysis of 34 Cases of Inherited Junctional Epidermolysis Bullosa caused by COL17A1 Mutations.

The British journal of dermatology
2020

Inherited epidermolysis bullosa: update on the clinical and genetic aspects.

Anais brasileiros de dermatologia
2020

The photobiomodulation therapy together with the use of cord blood platelet gel could be safely suggested as primary treatment for oral lesions in patients with inherited epidermolysis bullosa.

Photodermatology, photoimmunology &amp; photomedicine
2020

Successful dapsone therapy in inherited epidermolysis bullosa.

Journal of the European Academy of Dermatology and Venereology : JEADV
2020

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.

The British journal of dermatology
2020

Hoarse cry in a newborn with epidermolysis bullosa simplex, generalized severe.

Pediatric dermatology
2019

Bullous Diseases in Children: A Review of Clinical Features and Treatment Options.

Paediatric drugs
2019

Occupational therapy for epidermolysis bullosa: clinical practice guidelines.

Orphanet journal of rare diseases
2020

A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management.

Clinical nutrition (Edinburgh, Scotland)
2019

A retrospective cohort study evaluating the accuracy of clinical diagnosis compared with immunofluorescence and electron microscopy in children with inherited epidermolysis bullosa.

The British journal of dermatology
2019

Inherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography.

Journal of the European Academy of Dermatology and Venereology : JEADV
2018

[Inherited epidermolysis bullosa].

Arkhiv patologii
2018

Cord blood platelet gel for the treatment of inherited epidermolysis bullosa.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
2019

Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes.

Experimental dermatology
2018

Burnlike scars: A sign suggestive of KLHL24-related epidermolysis bullosa simplex.

Pediatric dermatology
2018

Advances in understanding the molecular basis of skin fragility.

F1000Research
2017

IL-6/IL-10 Ratio as A Prognostic and Predictive Marker of the Severity of Inherited Epidermolysis Bullosa.

Iranian journal of immunology : IJI
2017

Diagnosis of Inherited Epidermolysis Bullosa in Resource-Limited Settings: Immunohistochemistry Revisited.

Dermatology (Basel, Switzerland)
2017

Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases.

Experimental dermatology
2017

Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex.

Orphanet journal of rare diseases
2017

Bullous, pseudobullous, & pustular dermatoses.

Seminars in diagnostic pathology
2017

Development of a clinical diagnostic matrix for characterizing inherited epidermolysis bullosa.

The British journal of dermatology
2016

Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa.

International journal of molecular sciences
2016

Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.

Orphanet journal of rare diseases
2016

Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry.

JAMA dermatology
2016

Research Techniques Made Simple: Immunofluorescence Antigen Mapping in Epidermolysis Bullosa.

The Journal of investigative dermatology
2016

Kaposi varicelliform eruption in a patient with epidermolysis bullosa simplex generalized severe.

JAAD case reports
2016

Molecular therapies for inherited epidermolysis bullosa.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia
2016

Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial.

Orphanet journal of rare diseases
2016

Treatment of feet deformities in epidermolysis bullosa.

International orthopaedics
2016

Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia.

Experimental dermatology
2015

Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa.

Medicine
2015

Generalized severe junctional epidermolysis bullosa with congenital absence of skin in churra lambs.

Veterinary dermatology
2015

Systemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): Results of a pilot trial.

Journal of the American Academy of Dermatology
2014

Pain care for patients with epidermolysis bullosa: best care practice guidelines.

BMC medicine
2015

Oral erythromycin therapy in epidermolysis bullosa simplex generalized severe.

The British journal of dermatology
Ver todos os 97 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Epidermólise bolhosa hereditária.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Epidermólise bolhosa hereditária

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The lived experience and supportive care needs of Australian parents caring for children with Epidermolysis Bullosa: a qualitative descriptive analysis.
    Orphanet journal of rare diseases· 2025· PMID 41318628mais citado
  2. Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol.
    PloS one· 2025· PMID 40971360mais citado
  3. Junctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion.
    International journal of molecular sciences· 2025· PMID 40806473mais citado
  4. Clinical and Allelic Heterogeneity in a Small Cohort of Patients with Inherited Epidermolysis Bullosa.
    International journal of molecular sciences· 2025· PMID 40565224mais citado
  5. An International Online Survey on Oral Hygiene Issues in Patients with Epidermolysis Bullosa.
    Dentistry journal· 2025· PMID 41002671mais citado
  6. Topical Gentamicin in the Management of Bart Syndrome: A Case Report.
    Cureus· 2026· PMID 41890490recente
  7. Stem cell therapy: a promising frontier in modern medicine with a comprehensive overview of their biology and potential therapeutic applications in chronic non-healing cutaneous injuries.
    Inflammopharmacology· 2025· PMID 40908441recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79361(Orphanet)
  2. MONDO:0019276(MONDO)
  3. Epidermólise Bolhosa (Diretriz Brasileira)(PCDT · Ministério da Saúde)
  4. GARD:18992(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55788582(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Epidermólise bolhosa hereditária
Compêndio · Raras BR

Epidermólise bolhosa hereditária

ORPHA:79361 · MONDO:0019276
🇧🇷 Brasil SUS
Geral
Prevalência
1-9 / 1 000 000
Herança
Autosomal dominant, Autosomal recessive
Ensaios
1 ativos
Medicamentos
9 registrados
Início
All ages
Prevalência
0.8 (Europe)
MedGen
UMLS
C1274224
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Medicamentos (literatura)
fonte: Orphanet